v3.25.2
Revenue Recognition (Tables)
6 Months Ended
Jun. 30, 2025
Revenue Recognition [Abstract]  
Schedule of Revenue by Product Category

The following table presents the Company’s revenue by product category for the six months ended June 30, 2025, and 2024:

 

   For the Six Months Ended
June 30,
 
   2025   2024 
Training  $279,885   $267,827 
Product supplies   1,030,089    769,237 
Equipment   8,435    102,060 
Patient procedures   1,029,450    471,239 
Total revenue  $2,347,859   $1,610,363 
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Loss

Listed below are the revenues, cost of revenues, gross profits, assets and net loss by Company:

 

   For the Six Months Ended 
   June 30, 2025 
   Global Stem
Cells Group
   Regenerative
Medical
Technology
Group
   Total 
Revenue  $2,347,859   $
-
   $2,347,859 
Cost of revenue   818,133    
-
    818,133 
Gross profit  $1,529,726   $
-
   $1,529,726 
Gross Profit %   65.15%   0.00%   65.15%
                
Net loss  $(7,579)  $(2,058,246)  $(2,065,825)
Assets  $2,666,976   $1,819,853   $4,486,828